We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+5.28%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.8B
AUM Growth
+$1.26B
(+7.6%)
Cap. Flow
+$567M
Cap. Flow
% of AUM
3.2%
Top 10 Holdings %
Top 10 Hldgs %
11.28%
Holding
2,904
New
221
Increased
694
Reduced
820
Closed
148
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McKesson
MCK
|
+$82.7M |
| 2 |
PepsiCo
PEP
|
+$76.8M |
| 3 |
Marriott International
MAR
|
+$64.8M |
| 4 |
Tyson Foods
TSN
|
+$62.8M |
| 5 |
PARA
Paramount Global Class B
PARA
|
+$52.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$64.8M |
| 2 |
Hormel Foods
HRL
|
+$61.4M |
| 3 |
Gilead Sciences
GILD
|
+$59.9M |
| 4 |
Hilton Worldwide
HLT
|
+$54.7M |
| 5 |
TechnipFMC
FTI
|
+$51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.87% |
| 2 | Healthcare | 14.18% |
| 3 | Financials | 11.71% |
| 4 | Industrials | 10.79% |
| 5 | Consumer Discretionary | 10.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Brunswick
BC
$5.19B
| $34.7M | 0.2% |
710,987
+313,059
| +79% | +$14.9M |
|
152
Equifax
EFX
$20.3B
| $34.7M | 0.2% |
257,691
+123,915
| +93% | +$16.4M |
|
153
Masco
MAS
$16B
| $34.6M | 0.2% |
1,009,603
+184,867
| +22% | +$6.39M |
|
154
ICU Medical
ICUI
$3.93B
| $34.6M | 0.19% |
273,427
+263,917
| +2,775% | +$31.8M |
|
155
iShares Russell 2000 ETF
IWM
$80.9B
| $34.5M | 0.19% |
278,162
-8,760
| -3% | -$1.06M |
|
|
WOOF
156
DELISTED
VCA Inc.
WOOF
| $34.3M | 0.19% |
490,286
-176,970
| -27% | -$12.4M |
|
|
HOLX
157
DELISTED
Hologic
HOLX
| $34.3M | 0.19% |
882,134
+145,211
| +20% | +$5.48M |
|
158
NOV
NOV
$7.45B
| $34.1M | 0.19% |
929,087
+409,578
| +79% | +$13.8M |
|
159
Yum! Brands
YUM
$41B
| $34M | 0.19% |
520,995
-15,316
| -3% | -$978K |
|
160
Methode Electronics
MEI
$543M
| $33.8M | 0.19% |
967,209
+127,831
| +15% | +$4.49M |
|
161
Globus Medical
GMED
$10.4B
| $33.6M | 0.19% |
1,489,790
+4,639
| +0.3% | +$109K |
|
162
American Express
AXP
$223B
| $33.6M | 0.19% |
524,923
-58,195
| -10% | -$3.74M |
|
|
AEL
163
DELISTED
American Equity Investment Life Holding Company
AEL
| $33.6M | 0.19% |
1,895,415
-176,377
| -9% | -$2.91M |
|
164
Wolverine World Wide
WWW
$1.54B
| $33.6M | 0.19% |
1,458,006
+87,711
| +6% | +$2.04M |
|
165
EPR Properties
EPR
$4.86B
| $33.4M | 0.19% |
424,722
-149,936
| -26% | -$12M |
|
166
Ziff Davis
ZD
$1.9B
| $33.2M | 0.19% |
573,252
+85,125
| +17% | +$4.95M |
|
167
CME Group
CME
$92.2B
| $32.8M | 0.18% |
313,423
-37,169
| -11% | -$3.88M |
|
168
Fabrinet
FN
$17.1B
| $32.7M | 0.18% |
732,929
-179,566
| -20% | -$7.13M |
|
169
Omnicell
OMCL
$1.86B
| $32.7M | 0.18% |
852,750
-200,570
| -19% | -$7.48M |
|
170
Labcorp
LH
$24.3B
| $32.5M | 0.18% |
275,432
+993
| +0.4% | +$117K |
|
171
Stanley Black & Decker
SWK
$14.2B
| $32.5M | 0.18% |
263,914
-21,218
| -7% | -$2.56M |
|
|
HW
172
DELISTED
Headwaters Inc
HW
| $32.4M | 0.18% |
1,915,666
+262,861
| +16% | +$4.85M |
|
173
CVS Health
CVS
$137B
| $32.4M | 0.18% |
363,991
-234,168
| -39% | -$22.1M |
|
174
Vanguard Small-Cap ETF
VB
$79.5B
| $32.4M | 0.18% |
265,014
+6,893
| +3% | +$834K |
|
175
Ingredion
INGR
$6.38B
| $32.1M | 0.18% |
241,433
-78,133
| -24% | -$10.4M |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q3 2016 Portfolio in Review
As of Q3 2016, Glenmede Trust held 2,904 positions worth $17.8B, up 7.6% from $16.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Glenmede Trust deployed $567M of net new capital in Q3 2016, opening 221 new positions and adding to 694 existing holdings. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Starbucks, an estimated $64.8M trimmed.
- Glenmede Trust's largest Q3 2016 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.
- Glenmede Trust added most to McKesson in Q3 2016, an estimated $82.7M increase.
- Glenmede Trust's biggest Q3 2016 reduction was Starbucks, cutting an estimated $64.8M.
- Glenmede Trust fully exited WILSHIRE BANCORP INC in Q3 2016, selling an estimated $18.5M.
- Glenmede Trust's ten largest holdings make up 11% of its $17.8B portfolio in Q3 2016.
- Glenmede Trust opened 221 new positions and closed 148 in Q3 2016.
- Glenmede Trust's portfolio value rose 7.6% quarter-over-quarter to $17.8B.
Based on Glenmede Trust's 13F filing for Q3 2016, filed 14 Nov 2016.